Skip to main content
Fig. 3 | BMC Genomics

Fig. 3

From: Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma

Fig. 3

Knockdown of MYEOV, KCNN4, S100A16, and DDX60L expression through siRNA. (A) Expression of MYEOV, KCNN4, FAM83A, S100A16, and DDX60L in pancreatic cancer cells using data from the CCLE database (CCLE-PAAD). (B) Expression of MYEOV, KCNN4, FAM83A, S100A16 and DDX60L in MiaPaca2 pancreatic cancer cell (compared with the expression of GAPDH). (C) Screening for siRNAs that could knock down the expression of MYEOV and DDX60L in MiaPaca2 cells. (D, E) Knockdown of MYEOV and DDX60L expression with indicated siRNAs in MiaPaca2 cells (D) and PANC-1 cells (E)

Back to article page